Study of muscle strength using hand-held dynamometry in pediatric patients with obesity

Álvaro Martín Rivada1, Mercedes Murray Hurtado1, Elena Sánchez Camacho2

  • 1Servicio de Pediatría, Sección Nutrición y Errores Innatos del Metabolismo, Complejo Hospitalario Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.

Anales De Pediatria
|February 11, 2026
PubMed

Insights

Children with obesity show normal muscle strength compared to peers. Fat-free mass is the key predictor of grip strength, emphasizing the importance of physical activity and lean mass.

Area of Science:

  • Pediatric Endocrinology
  • Sports Medicine
  • Nutritional Science

Background:

  • Childhood obesity is a growing concern with potential impacts on physical development.
  • Muscle strength is a crucial component of overall health and functional capacity in children.
  • Understanding factors influencing muscle strength in pediatric obesity is vital for targeted interventions.

Purpose of the Study:

  • To assess grip strength in children and adolescents with obesity against reference values.
  • To analyze the relationship between muscle strength, body composition, and clinical/biochemical markers.
  • To identify predictors of muscle strength in this population.

Main Methods:

  • Retrospective observational cohort study of 125 pediatric patients (6-16 years) with obesity.
  • Data collected included physical activity, anthropometrics, bioimpedance analysis, and dynamometry.
  • Comparison with reference values and correlation analyses were performed.

Main Results:

  • Children with obesity had a mean muscle strength Z-score of +0.71, not lower than reference values.
  • Fat-free mass was the strongest positive predictor of muscle strength.
  • Dynapenia (low muscle strength) was observed in 4.8%, particularly in prepubertal children.

Conclusions:

  • Muscle strength in children with obesity is comparable to healthy peers.
  • Fat-free mass is the primary determinant of muscle strength.
  • Physical activity and lean mass positively influence strength in pediatric obesity.
Abstract

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Muscles of the Forearm that Move the Hand and Fingers01:16

Muscles of the Forearm that Move the Hand and Fingers

The muscles of the forearm that move the wrist, hand, and digits are numerous and diverse. They can be classified into two groups based on their location and function — the anterior and posterior compartment muscles.
Anterior Compartment
The anterior compartment muscles originate from the humerus. They primarily function as flexors and are also known as flexor muscles. They typically insert on the carpals, metacarpals, and phalanges. The superficial layer includes the flexor carpi...
2.7K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
277
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
334
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
246
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
296